Investors in Life Science

Curitas Ventures is a Stockholm based VC, launched by Mikael Ahlström and Gerda Larsson in 2020. We invest in teams determined to build something out of the ordinary within the field of Disruptive Tech and Life Science.

Bonit Capital, a Swedish family-owned investment company, engages in diverse sectors and asset classes, including social investments and outcome models. In Venture Capital, Bonit focuses on life sciences, providing capital and industry expertise to ambitious founders in digital health, medical technology, and diagnostics.

Crosslight Partners tackles substantial challenges within the food system with innovative solutions. These companies are at the early growth stage, demonstrating commercial traction. Investments typically range from SEK 1 to 10 million, with flexible ownership stakes. While the focus is global, emphasis lies on the Nordics and Europe. The investment horizon spans 3 to 7 years, and governance involvement includes securing a board seat or holding quarterly follow-up meetings.

The Nordic region is at the forefront of the technology and scientific revolution. Northislet's vision is to help create and build Nordic champions within Life Science, allowing them to grow and reach their potential in the hands of local entrepreneurs, employees, and shareholders. Their goal is to create long-term value for all stakeholders, fostering a prosperous environment for new and existing companies, entrepreneurs, and scientists, making the Nordic region a competitive and attractive place for global talent within Life Science. Northislet aims to become a leading Nordic investment company in Life Science over the next 25 years, with the journey just beginning.

Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.

Seed Capital de Bizkaia aims to promote and develop new or existing companies that seeks to develop socially innovative projects. SEED CAPITAL BIZKAIA, Sociedad Gestora de Entidades de Inversión de Tipo Cerrado SA (SGEIC) is a Public Company attached to the Department of Economic Promotion of the Provincial Council of Bizkaia, dedicated to the administration and management of various financing instruments. Founded in 1989, Seed Capital Bizkaia has been firmly committed to promoting innovation, social impact and the promotion and regeneration of the business fabric in Bizkaia for more than 30 years.

"NARA Ventures bridges the gap between investors and the world's leading VC funds, offering unique access to top-tier venture capital funds to deliver robust returns. Our experienced management team connects you with global innovators and technology leaders. As a fund of funds, we provide strategic asset allocation, minimizing risk while maximizing growth potential. With a proven track record, NARA Ventures delivers reliability and trust, making it your gateway to transformative investment opportunities. We invest in top-tier VCs through our strategic alliance with PlugAndPlay, across different sectors, technologies, and geographies."

LifeLink Ventures facilitates direct access for private investors to exclusive life sciences opportunities. They focus on identifying critical therapies led by ambitious entrepreneurs and linking them with a network of investors. Their mission underscores a commitment to deploying capital strategically to advance global health outcomes, aligning investments with impactful causes.

Hadean Ventures is a European life science VC fund manager investing in healthcare innovation across the Nordic region, with a diverse portfolio spanning pharmaceuticals, medical tech, diagnostics, and digital health.